From March 2020 we will no longer accept or send faxes. Please click here for other ways to contact us.
June 2018: Change in Practice – Post pregnancy hCG follow-up on molar pregnancy patients.
In July 2017 we ceased monitoring any pregnancies subsequent to molar pregnancy in women with a single molar event not requiring chemotherapy. Data analysis shows the risk of developing recurrent/new disease is extremely low at 1:4,110. For women with multiple moles (more than one) and women treated with chemotherapy we continue to monitor.
This data will be published shortly and will be reflected in the forthcoming revised RCOG guidelines.
- Bi-monthly patient drop-in sessions held in February, April, June, August, October and December each year. Newly diagnosed patients are invited to attend our bi-monthly sessions held at Charing Cross Hospital. For further information please contact the Advisory team on tel: 020 3311 1409
- The International Society for the Study of Trophoblastic Diseases (the ISSTD) holds biennial symposia for its members. For further details please visit the ISSTD website at www.isstd.org/isstd/home.html
- Fundraising. If you wish to provide your support and help raise money for research please either see our page detailing forthcoming events or visit our charity website CTRT.org or our webpage on the just giving site.